scispace - formally typeset
R

Ruediger E. Port

Researcher at Genentech

Publications -  23
Citations -  4268

Ruediger E. Port is an academic researcher from Genentech. The author has contributed to research in topics: Population & Dynamic contrast-enhanced MRI. The author has an hindex of 17, co-authored 23 publications receiving 4047 citations. Previous affiliations of Ruediger E. Port include German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

MR imaging of tumor microcirculation: Promise for the new millenium

TL;DR: Clinical studies in this section show that some tumor types can be assessed by relatively simple dynamic measures and analyses, and suggest that a consensus on naming conventions (nomenclature) is needed to facilitate comparison and analysis of the results of studies conducted at different centers.
Journal ArticleDOI

Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors.

TL;DR: The shortest mean residence time in one of up to three tumor compartments, MRT*, was estimated using either the individual (reference) or a mean population arterial input function (AIF), which was unbiased but differed from the reference estimates 1.5‐fold or more in 23% of cases.
Journal ArticleDOI

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.

TL;DR: It is concluded that individual CM kinetics in arterial blood should be taken into account when CM exchange rates between blood and tumor are to be determined and that a kinetic model for potentially malignant tumors should allow for kinetic heterogeneity.
Journal ArticleDOI

Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.

TL;DR: The method, which has a natural interpretation within the framework of a two-mutation model for carcinogenesis, yields estimates of rates of initiation and of growth rates of enzyme-altered foci as functions of dose of the agent under consideration.